Correction to: Nature Communications https://doi.org/10.1038/s41467-021-25422-9, published online 25 August 2021.
The original HTML version of this Article was updated shortly after publication because the previous HTML version linked to an incorrect Transparent Peer Review file.
About this article
Cite this article
Alves, C.L., Ehmsen, S., Terp, M.G. et al. Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nat Commun 12, 5588 (2021). https://doi.org/10.1038/s41467-021-25901-z